| |
Experience has been gained with medical devices, new chemical entities, new biological products and licensed pharmaceuticals in the following areas:
| Cardiovascular: |
Ischemic heart disease, hypertension, heart failure, erectile dysfunction, pulmonary hypertension |
| CNS: |
Stroke, dementia |
| Infectious diseases: |
Community and hospital acquired pneumonia, acute exacerbation of chronic bronchitis, sinusitis, skin and skin structure infections, intra-abdominal infections, urinary tract infections, pediatric indications |
| Oncology: |
All solid tumors in phase one setting, ovarian cancer, breast cancer, colorectal cancer, non-small cell lung cancer, renal cell cancer, hepatoma |
| Rheumatology: |
Osteoarthritis |
| Haematology: |
Haemophilia, idiopathic thrombocytopenia purpura, peri-operative bleeding, deep vein thrombosis, prevention of thromboembolic phenomena |
| Respiratory: |
Asthma, COPD |
| Dermatology: |
Acne, psoriasis, different tineas |
| Metabolic: |
Diabetes mellitus, hyperlipidemia |
| Intensive Care: |
Open heart surgery, sepsis, septic shock |
| Gynecology: |
Pelvic inflammatory disease |
| Gastroenterology: |
Inflammatory bowel disease |
|
